Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All

Hedge Fund Under SEC Microscope Over Cougar Deal

October 21, 2011 7:20 am | News | Comments

Hedge fund SAC Capital Advisors LP is being investigated by federal regulators for using inside information to profit from a health care takeover in 2009, the Wall Street Journal reported.

TOPICS:

Amgen Likely to Highlight Sales Prospects

October 21, 2011 7:16 am | News | Comments

Amgen Inc., the world's largest biotech company by revenue, likely will focus on sales prospects for its top drugs and progress on its experimental drugs when it reports third-quarter results.

TOPICS:

EU Opens Antitrust Probe into Novartis, J & J

October 21, 2011 7:12 am | News | Comments

The European Union is investigating whether drug companies Novartis and Johnson & Johnson colluded to keep a generic painkiller out of the Dutch market, the bloc's antitrust watchdog said.

TOPICS:
Advertisement

Early HIV Treatment Increases Tuberculosis Patients Survival

October 20, 2011 12:38 pm | News | Comments

Starting HIV therapy in patients with both HIV and tuberculosis within two weeks of TB treatment increases survival by 33%.

TOPICS:

Byetta Approved for Insulin Glargine Use

October 20, 2011 12:35 pm | News | Comments

Amylin Pharmaceuticals, Inc. and Eli Lilly and Company announced that the U.S. Food and Drug Administration has approved a new use for Byetta (exenatide) injection.

TOPICS:

Bristol-Myers Squibb Senior VP Departs

October 20, 2011 12:32 pm | News | Comments

Drugmaker Bristol-Myers Squibb Co. said that its commercial operations senior vice president, Anthony C. Hooper, has left the company.

TOPICS:

Common Link Between Autism, Diabetes

October 20, 2011 12:28 pm | News | Comments

A review of the genetic and biochemical abnormalities associated with autism reveals a possible link between the widely diagnosed neurological disorder and Type 2 diabetes.

TOPICS:

Syntaxin, Ipsen Enter Agreement

October 20, 2011 12:24 pm | News | Comments

Ipsen and Syntaxin announced a global strategic collaboration to explore the discovery and development of new compounds in the field of botulinum toxins.

TOPICS:
Advertisement

Synergy Health Hires Business Development Manager

October 20, 2011 12:19 pm | News | Comments

Synergy Health announced the appointment of Steve Poynter as business development manager.

TOPICS:

Changes in Bristol-Myers Squibb Management Team

October 20, 2011 12:12 pm | News | Comments

Bristol-Myers Squibb announced a series of changes within its senior management team.

TOPICS:

LIMS System

October 20, 2011 6:12 am | Drug Discovery & Development | Product Releases | Comments

LabLogic Systems is launching Version 6 of its Debra LIMS for drug metabolism studies. This version makes provision for new ways of working in pharmaceutical research and rationalizes complexities.

TOPICS:

Magnetic Mixer

October 20, 2011 6:09 am | Product Releases | Comments

Sartorius Stedim Biotech has expanded its range of Flexel products and now offers 1,500 L and 2,000 L volumes, as well as scalable, ready-to-use mixing technology to enhance process flexibility in biomanufacturing and optimize manufacturing costs.

TOPICS:

Ricerca Partners with Jeanne Stadler

October 20, 2011 5:56 am | News | Comments

Ricerca Biosciences has announced a partnership agreement with Dr. Jeanne Stadler, a well-known consultant who specializes in reproductive and developmental toxicology.

TOPICS:

Non-natural Flavanones Developed As Antimicrobials

October 20, 2011 5:43 am | News | Comments

A new paper reports the synthesis and testing of a family of potential antimicrobial molecules and finds that their therapeutic effect is comparable to that of many currently used antimicrobial agents.

TOPICS:

Regulus Releases New miR-33 Data

October 20, 2011 5:37 am | News | Comments

Regulus Therapeutics Inc. and collaborators announced the publication of new data showing the first demonstration of marked increases in high density lipoprotein cholesterol, and suppression of plasma triglyceride levels.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading